课题基金 / 基金详情

A development platform for mutation-resistant vaccines and antibodies for SARS-CoV-2 future variants

A development platform for mutation-resistant vaccines and antibodies for SARS-CoV-2 future variants
针对 SARS-CoV-2 未来变种的抗突变疫苗和抗体的开发平台
批准号:
473342
负责人:
Plotkin Steven S
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-09-01 至 2023-09-01

项目摘要

项目成果

Plotkin Steven S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Globally, as of August 2022, there have been an estimated 600 million cases of COVID-19 worldwide, and over 6.4 million deaths. Novel variants of SARS-CoV-2 virus continue to emerge and escape immunity by either previous infection or vaccination, resultin
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A platform for developing mutation-resistant vaccines and antibodies for future viral variants, using SARS-CoV-2 as a model
  • 批准号:
    494497
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2023
  • 负责人:
    Plotkin Steven S
  • 依托单位:
Computation and theory to predict structures and mechanisms for protein misfolding in amyotrophic lateral sclerosis
  • 批准号:
    321932
  • 项目类别:
    Operating Grants
  • 资助金额:
    $46.38万
  • 财政年份:
    2015
  • 负责人:
    Plotkin Steven S
  • 依托单位:
Computation and theory to predict structures and mechanisms for protein misfolding in degenerative disease
  • 批准号:
    309396
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Plotkin Steven S
  • 依托单位:
Molecular Origins of Protein Misfolding and Neurodegenerative Disease
国内基金
海外基金
联合基因组重测序和10× Genomics scRNA-Seq解析乌骨鸡胸肌黑色素转运的分子机制
  • 批准号:
    32072711
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2020
  • 负责人:
    郭松长
  • 依托单位:
Journal of Genetics and Genomics